The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 28, 2026
Filed:
May. 04, 2022
Applicant:
Mbd Co., Ltd., Suwon-si, KR;
Inventors:
Bo Sung Ku, Suwon-si, KR;
Ho Sang Moon, Suwon-si, KR;
Do Hyeong Na, Seoul, KR;
Mi Sun Kim, Gwacheon-si, KR;
Han Som Park, Suwon-si, KR;
Assignee:
MBD CO., LTD., Suwon-si, KR;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 401/14 (2006.01); A61K 31/496 (2006.01); A61K 31/517 (2006.01); A61P 1/16 (2006.01); A61P 3/10 (2006.01); C07D 405/14 (2006.01); C07D 409/14 (2006.01); C07D 413/14 (2006.01); C07D 417/14 (2006.01);
U.S. Cl.
CPC ...
C07D 401/14 (2013.01); A61K 31/496 (2013.01); A61K 31/517 (2013.01); A61P 1/16 (2018.01); A61P 3/10 (2018.01); C07D 405/14 (2013.01); C07D 409/14 (2013.01); C07D 413/14 (2013.01); C07D 417/14 (2013.01);
Abstract
The present invention relates to a novel quinoline or quinazoline compound and the use thereof. The compound according to the present invention shows an excellent inhibitory activity against cytochrome P450 4A (CYP4A) and thus may be utilized for preventing, relieving or treating metabolic diseases.
Ku, Bo. (2026). Heterocyclic cyp4a inhibitor compounds and compositions thereof (U.S. Patent No. 12612384). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12612384
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile